Tyler Research Institute, LLC /ID# 166796

322 East Southeast Loop 323
Tyler, Texas 75701

We've found

1 trials

at this facility

A Study of the Efficacy and Safety of Risankizumab in Subjects With Moderately to Severely Active Crohn's Disease

Status: Enrolling, Phase III
Updated: 12/31/1969

from

Tyler, TX

Use our guide to learn which trials are right for you!